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ABSTRACT 
Diabetes Mellitus is a metabolic disorder affecting a large proportion of world's population. It is characterized by the appearance of persistent 
hyperglycemic conditions in affected individuals due to the incompetency of bodily mechanisms to curb the rising glucose levels in the blood. 
Medicinal plants are utilized since the ancient times as the source of therapeutic agents for the treatment and cure of a variety of disorders. The 
use of medicinal plant in the traditional systems of medicines for the management or  treatment of diabetes have provided admirable results 
suggesting a potential role that herbals can play in the management of the disorder. The ease of access, affordability and the ability of herbals to 
produce minimum side effects on administration has convinced a major portion of population globally to switch to this alternative approach of 
medicine. Moreover, a number of studies have suggested that the medicinal plants employ the multi target approaches that make them least 
susceptible to failure during the course of treatment. The present review summarizes the antidiabetic profile of medicinal plants found in the 
Indian subcontinent that are evaluated for their hypoglycemic activity. Medicinal plants showing prominent anti-diabetic activity during the 
initial studies should be further explored to identify the active principles present in them that can become the promising drug candidates for the 
disease treatment in the coming future.       
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INTRODUCTION 
Diabetes mellitus is the chronic condition of abnormally 
elevated levels of glucose in the blood. With an elevation in 
blood glucose level, the release of hormone insulin occurs 
from the beta cells of pancreas. Insulin is the major 
metabolic hormone in the body. It stimulates muscle and fat 
cells to reduce the glucose levels from the blood as well as 
stimulates the liver for glucose metabolism, thus effectively 
reducing blood glucose levels by various mechanisms. 
Diabetic patients tend to have a chronically high blood 
glucose levels. Two reasons can be attributed to this. Either 
there is not enough insulin produced by the Beta cells (Type 
1 diabetes) or there may be reduced sensitivity of body cells 
to insulin (Type 2 diabetes). Type 1diabetes is generally 
considered as an autoimmune disorder where the body’s 
defense mechanisms fail to recognize the self-pancreatic 
cells and produce immune mechanisms against them, thus 
destructing the insulin-producing Beta cells. This type of 
diabetes is rare and occurs in around 5% diabetic 
population. Type 1 diabetes is also known as insulin 
dependent diabetes mellitus or IDDM. Type 2 diabetes 
affects a majority of diabetic patients. It is also known as 
Non-insulin dependent diabetes mellitus or NIDDM. 1 
Apart from Type 1 & 2 diabetes, conditional diabetes like 
situation may also arise. As in case of Gestational diabetes, 
pregnant mother may be diagnosed diabetic during 
pregnancy which may or may not subside after childbirth. 
Diabetes can also be drug-induced, for example: in the case 
of patients taking glucocorticoids, glucose levels in the blood 
increases till the treatment is continued. Discontinuation of 
glucocorticoids brings back the normoglycaemic condition. 
Another example would be a person treated with thiazides 
who develops diabetes years later. 2 
Types of Diabetes 
In general considerations, all forms of diabetes are 
categorized under the two major forms of diabetes i.e. Type 
1 and Type 2 diabetes: 
Type 1 Diabetes  
Type 1 diabetes is considered as an autoimmune disorder 
where the body’s defense mechanisms fail to recognize the 
self-pancreatic cells and produce immune mechanisms 
against them, thus destructing the insulin-producing Beta 
cells. The chances of occurrence of this form of diabetes is 
generally rare when compared with other forms of diabetes 
and is generally seen in around 5- 10% of diabetic 
populations. Auto destruction of beta cells in type-1 diabetes 
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is caused by islet cell autoantibodies, insulin directed 
antibodies, autoantibodies towards Glutamic Acid 
Decarboxylase or GAD or antibodies directed towards the 
tyrosine phosphatases. When diagnosed with Type-1 
diabetes, multiple antibodies towards pancreatic cells are 
detected in the patient's blood. Association with HLA gene is 
also suspected to act as a predisposing factor for the cause of 
this type of diabetes.  
Destruction of Beta cells in type-1 diabetes may vary from 
patient to patient. Destruction may be rapid in some 
individuals as in case of infants and children or slow as in 
case of adults and elderly. The first sign of type-1 diabetes in 
children and adolescents is the appearance of ketoacidosis in 
diagnosis. Moderate hyperglycemia leading to severe 
hyperglycemia and ketoacidosis in the presence of infections 
may also occur in some children. Adult patients tend to 
retain the residual beta cell functions to prevent ketoacidosis 
for several years by completely depending on external 
insulin and live at a lower risk of ketoacidosis.  
Multiple genetic predispositions are thought to induce 
autoimmune destruction of β-cells. Patients of Type-1 
diabetes also remain at a higher risk of developing other 
autoimmune disorders that may include Graves' disease, 
Hashimoto's thyroiditis, Addison's disease, vitiligo, celiac 
sprue, autoimmune hepatitis, myasthenia gravis, and 
pernicious anemia. 2 
A small proportion of type-1 patients may have chronic 
insulinopenia and are much prone to ketoacidosis but show 
no symptoms of an autoimmune disorder. This form of 
diabetes is strongly inherited but is not HLA associated. Such 
patients may also suffer from frequent ketoacidosis with 
varying degree of insulin levels between episodes of 
ketoacidosis. The requirement of insulin in the affected 
individuals with this type of diabetes may vary. 2 
Type 2 Diabetes  
Type-2 or adult-onset form of diabetes affects a majority of 
the population (around 90-95%) and is characterized by 
insulin resistance and relative insulin deficiency. These 
patients generally do not need insulin replacement for their 
survival.  
A majority of type-2 diabetes patients suffer from obesity 
that leads to additional insulin resistance. In non-obese type-
2 diabetes patients, body fat distribution occurs 
predominantly in the abdominal region. Ketoacidosis is a 
rare condition in type-2 diabetes; although infection or 
stress factor may lead to ketoacidosis in such patients. 
Patients with type-2 diabetes are at a higher risk of 
developing macrovascular and microvascular complications. 
Insulin levels in such patients appear to be normal, the 
higher blood glucose levels even in the presence of insulin 
leads to the conclusion that beta cells are functional and the 
elevation in glucose levels is due to some other factor. While 
resistance to insulin can be improved with therapeutic 
approaches or by lifestyle modifications such as weight 
reduction, complete restoration of the normoglycemic 
condition is seldom observed. Age, obesity, hypertension and 
lack of physical activities may increase the risk of type-2 
diabetes. Gestational diabetes (a form of conditional 
diabetes) may also take the form of permanent type-2 
diabetes after childbirth in women if proper measures are 
not taken. Association of type-2 diabetes with genetic 
predispositions is strongly believed to exist although clear 
mechanisms are poorly understood in this case. 2    
Common symptoms of diabetes include frequent urination, 
excessive thirst, increased appetite, fatigue, blurred vision, 
slow wound healing, weight loss – regardless of increased 
appetite (type 1), tingling, pain, or numbness of hands/feet 
(type 2). 3 
PHYSIOLOGY AND BIOCHEMISTRY OF GLUCOSE 
REGULATION 
Overview of Glucose Metabolism 
Glucose is the major fuel to fulfill the cellular energy 
demands in the body. The glucose in the blood is regulated 
mainly by insulin and has varying fates in the human body. It 
generates energy molecules (ATP) by converting into a three 
carbon molecule, Pyruvate which then enters the 
tricarboxylic acid (TCA) cycle and oxidative phosphorylation 
in mitochondria. Excess of glucose in the blood is converted 
into fat and glycogen that act as long term and short term 
deposits of energy molecules respectively. 
In the presence of an excess of glucose in the blood, Insulin is 
released to handle the blood glucose levels. Upon release, 
Insulin exerts the following actions on body cells: 
• Activate insulin dependent GLUT-4 transporters in 
muscle and fat cells to shift glucose from the blood to 
the adipose tissue. 
• Increase peripheral uptake of glucose by cells for its 
breakdown in the energy-releasing molecules, releasing 
their energy in the form of ATP (via glycolysis -TCA 
cycle-Oxidative phosphorylation pathway) 
• Stimulates hepatocytes in the liver and muscle cells to 
store glucose in the form of glycogen that acts as the 
short term reserve of energy. 
Another hormone called Glucagon is released from the alpha 
cells in islets of Langerhans of pancreas that opposes the 
actions of insulin. Blood with low levels of glucose when 
passes through the capillaries in the islets of Langerhans; 
alpha cells sense the low levels of glucose in blood and 
release Glucagon to increase the glucose levels in the blood 
by depleting glucose stores. On contrary to insulin action 
that stimulates the formation of glycogen from glucose, 
glucagon reverses insulin action and converts the glycogen 
into glucose. Glucagon also depletes fats and proteins to 
generate energy when glucose levels in the body are scarce. 1 
Regulation of Blood Glucose 
Blood glucose levels fluctuate as per the body’s 
requirements. These fluctuating levels of glucose in blood 
should lie in the range 70 to 110 mg/dl of blood to ensure 
the normal functioning of metabolic machinery of the body. 
The levels of glucose in the blood raise under three 
conditions: diet, glycogen breakdown or hepatic synthesis of 
glucose. 
Elevation of glucose levels with diet depends upon the 
glycemic index (higher in case of carbohydrates intake) and 
rates of absorption and digestion. Transport of glucose 
across the biological membranes takes place by the 
utilization of special transporters called Glucose 
transporters or GLUTs. Six types of GLUT transporters are 
known (GLUT 1-5, 7). GLUT 1&3 transporters have a high 
affinity for glucose. These transporters shift the glucose from 
the blood to cells down the concentration gradient and are 
found in high concentration in neurons where a continuous 
supply of glucose is mandatory. These transporters are not 
insulin dependent. GLUT-2 transporters are bidirectional 
and are found in liver and beta cells of the pancreas where 
the bidirectional movement of glucose in desirable. GLUT-4 
is an insulin-sensitive transporter and its expression 
depends on the insulin concentration in blood. A high 
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increase in glucose levels in the blood triggers the insulin 
release that in turn stimulates the expression of GLUT-4 
receptors in adipose tissues to store excess glucose as energy 
stores in the form of fat. GLUT-5 receptors are fructose 
sensitive transporters. They are found in high concentration 
in testis, GIT and sperm cells. GLUT-7 receptors are found on 
smooth endoplasmic reticulum plays a vital role in the 
process of gluconeogenesis. 
The liver acts as the major machinery for the production of 
glucose. During starvation, it releases glucose from the 
glycogen and ensures that the levels of glucose in the blood 
lie in the normal range. Liver also synthesizes glucose from 
the intermediates of carbohydrate, protein, and fat 
metabolism. 1 
Insulin 
Insulin Synthesis 
The insulin gets synthesized in the beta cells of pancreas. 
Beta cells are found as clumps in the endocrine part of the 
pancreas called the “islets of Langerhans.” 
Insulin synthesis begins with the transcription of the insulin 
gene on chromosome no. 11. The mRNA synthesized during 
transcription is transported to the cytosol for the subsequent 
translation of mRNA to form insulin polypeptides. During the 
process of translation, two introns from mRNA are spliced 
out that encode 110 amino acids long protein. The primary 
translation product of insulin consists of an initial segment 
(24 amino acids long) and is called preproinsulin which is 
inactive. The initial segment is necessary for crossing the 
endoplasmic reticulum membrane. Once inside the 
endoplasmic reticulum, the preproinsulin is converted into 
proinsulin by the cleavage of the initial segment by protease 
enzymes. The proinsulin produced consists of three amino 
acid chains: the A chain, the B chain and the connecting C 
peptide chain linked together. 
The proinsulin inside the endoplasmic reticulum is further 
exposed to several specific peptidases that cleave the C- 
peptide chain from the A&B chains thus producing the active 
insulin. The mature insulin and C-peptide are then 
transferred to the Golgi apparatus to be packed as secretory 
granules in the beta cell’s cytosol. Entry of glucose stimulates 
the exocytosis of granules and insulin release. 1 
Insulin Structure 
Insulin molecule consists of two amino acid chains named 
chain A (21 amino acids) and chain B (30 amino acids). The 
chains A&B are linked together by 2 disulphide bridges. A 
third disulphide bridge also exists on A-chain that links the 
6th and 11th residues of the A chain together. 
The design of recombinant insulin is done in such a way that 
the propensity of insulin molecule to form dimers and 
hexamers is either prevented or reduced but its binding to 
insulin receptor is not compromised. This approach has 
enabled to prepare a wide range of recombinant insulin that 
varies in their duration of action from short acting to long 
acting. 1 
 Insulin Secretion 
As discussed already, the rising levels of glucose in the blood 
that are detected by the pancreatic beta cells trigger the 
insulin release. The secretion of insulin release from the beta 
cells is a multistep process. The sequence of events that 
occur in beta cells during the insulin release is as follows:  
• Type 2 glucose transporters (GLUT2) transport the 
glucose down the concentration gradient from blood to 
the cells. Once inside, the glucose is rapidly 
phosphorylated into glucose-6-phosphate by the 
enzymes Hexokinase and Glucokinase in some cells 
where a high concentration of glucose is handled. The 
enzyme hexokinase acts rapidly even in the presence of 
a small amount of glucose in cells. Glucokinase, on the 
other hand, acts slowly and only in the presence of high 
concentration of glucose in the cells. In scientific terms, 
hexokinase has less Km and Vmax while glucokinase has 
high Km and Vmax. Low Km and Vmax are desirable in 
almost all cells as a high concentration of glucose in 
normal cells is seldom achieved. Glucokinase is found to 
be active in liver cells where hepatocytes handle a high 
concentration of glucose and a high Km and Vmax are 
necessary. 
• Metabolism of glucose occurs through Glycolysis- TCA 
cycle- oxidative phosphorylation pathway that 
ultimately generates the energy molecules ATP. 
• Elevation in ATP levels inside the cells allows the 
binding of ATP to ATP sensitive-gated potassium 
channels in the beta cell membrane. Binding of ATP 
closes the potassium channels thus preventing the 
positively charged potassium ions (K+) from leaving the 
beta cells. 
• Intracellular positivity due to increased concentration of 
K+ causes depolarization in the beta cells. 
• Voltage-sensitive calcium channels open, allowing 
calcium ions (Ca2+) to flood inside the cell. 
• Intracellular increase in calcium concentration 
stimulates the secretion of insulin by the process of 
exocytosis. 
In response to the rise in glucose levels, insulin release 
occurs in two phases. During the first phase, an immediate 
release of insulin occurs from the secretory granules filled 
with preformed insulin. This is followed by a brief fall in 
insulin release. The second phase of insulin release occurs 
after this short delay is composed of newly synthesized 
insulin. This biphasic release of insulin gives a biphasic 
response curve of insulin towards increased glucose levels. 
Insulin exerts its action for a short duration after its release 
in the bloodstream. The presence of enzyme insulinase in 
liver and kidneys degrades the circulating insulin thus 
limiting the half-life of insulin to around 6 minutes. 1 
Insulin Receptor 
The binding of insulin to the insulin receptor initiates a 
cascade of phosphorylation and dephosphorylation reactions 
inside the cells. The action of insulin on the insulin receptor 
is terminated by dephosphorylation of the receptor. The 
insulin receptor is a tyrosine kinase receptor found 
embedded in the plasma membrane and is composed of pairs 
of alpha and beta subunits. The insulin binding site is located 
on the extracellular alpha subunit of the receptor. The beta 
subunit is present inside the cell-bound with tyrosine 
molecule.  
Binding of insulin to alpha subunits induces a 
conformational change in the receptor that signals the 
intracellular beta subunit to undergo phosphorylation. 
Phosphorylation of tyrosine of each beta subunit occurs 
along with other target proteins resulting in diverse cellular 
activities that are governed by insulin 1 
Insulin Action 
The binding of insulin to insulin receptor results in the 
expression of a wide range of biological actions that take 
place during its lifespan. Once released, insulin rapidly 
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increases the glucose uptake into many tissues that express 
insulin sensitive GLUT-4 transporters, such as skeletal 
muscle and fat. Insulin also enhances the transporters 
activity and number by increasing their recruitment from the 
cytoplasm to the cell surface. As discussed, not all tissues 
require insulin for glucose uptake; cells such as hepatocytes, 
RBCs, GIT cells, nephrons and cells of the neurons use GLUT-
1&3 glucose transporters which are independent of insulin 
action. Depending upon the phosphorylation of enzymes by 
insulin binding, the activity of these enzymes is altered 
variably with time. 1 
ANTI-DIABETIC DRUGS 
Metformin 
Metformin is a hypoglycemic agent that reduces plasma 
glucose levels by causing the inhibition of hepatic 
gluconeogenesis. Intestinal absorption of sugars is also 
reduced or retarded after the administration of metformin. 
Reduction in LDL and VLDL levels with an increase in HDL 
level is also seen in patients after 4-6 weeks long treatment 
with metformin. Secondary actions of Metformin include 
decreased appetite and reduction in cardiovascular 
mortality. Adverse effects of metformin may cause severe 
lactic acidosis especially in patients with congestive heart 
failure. Hypoglycemia may occur when metformin is 
combined with other antihyperglycemic agents. 
Nateglinide 
Nateglinide belongs to meglitinide class of hypoglycemic 
drugs. It binds to ATP sensitive K+ channels like 
sulfonylureas but with less affinity. They stimulate insulin 
synthesis by causing intracellular depolarization, thus, acting 
in a manner similar to sulfonylurea to promote insulin 
secretion with shorter onset and duration of action. It is 
effective in causing prandial and postprandial release of 
insulin. It produces less hypoglycemia in comparison to 
sulfonylurea due to their short duration of action. Its 
duration of action is prolonged by CYP3A4 inhibitors while 
decreased by CYP3A4 promoters. Combination with 
gembifrozil and repaglinide causes severe hypoglycemia. 4 
Pioglitazone 
Pioglitazone is an activator peroxisome proliferator-
activated receptor-γ (PPAR-γ). PPAR-γ agonists regulate the 
production of adipocytes, fatty acids secretion and 
metabolism of glucose. Pioglitazone binds to PPAR-γ 
receptors and increases the sensitivity of insulin to 
adipocytes, hepatocytes and skeletal muscle cells. An 
appreciable reduction in hyperglycemia, HbA1c levels and 
triglycerides levels with the increase in HDL levels after 
administration occurs. Subcutaneous accumulation of fats is 
seen in patients taking pioglitazone. Adverse effects include 
hepatotoxicity that may be fatal. Hepatic functions must be 
monitored routinely in patients taking pioglitazone. 
Concomitant administration with oral contraceptives may 
lead to the failure of contraceptives.  [4] 
Miglitol 
Miglitol is an oligosaccharide derivative that is generally 
taken before the meal to delay carbohydrate absorption and 
digestion. Miglitol inhibits glucosidase enzyme present in the 
intestinal brush borders that mediate the digestion of 
carbohydrates. Adverse effects include diarrhoea, flatulence 
and cramps. It is contraindicated in patients with intestinal 
pathology. 4 
Glimipride 
Glimipride is a long-acting sulfonylurea that acts by blocking 
ATP sensitive K+ channels. It works in a manner similar to 
meglitinides but has a longer duration of action. It enhances 
the number and binding of insulin to target cells and reduces 
glucagon secretion. Adverse effects include weight gain, 
hyperinsulinemia and hypoglycemia. Accumulation of 
glimepiride occurs due to hepatic and renal insufficiency 
leading to the associated risk of hypoglycemia.  4 
IMPORTANCE OF HERBAL MEDICINES 
Since ancient times, herbal remedies are used for the 
treatment of a variety of diseases and disorders. The use of 
medicinal herbs still continues to be an approach of choice 
for the treatment of ailments. Herbs are utilized in almost 
all cultures as the source of active therapeutic constituents. 
Their ease of access, affordability and lack of side effects 
make them acceptable approach for disease treatment 
especially in developing and underdeveloped countries 
where the modern system of medicine is poorly developed. 
A variety of active constituents are isolated from medicinal 
plants that have established themselves as potential 
candidates for disease treatment. Different species of 
medicinal plants are explored for their antidiabetic 
potential and are used in traditional medicinal practices to 
control diabetes. Before the advent of insulin, traditional 
plants were used extensively for the treatment of both 
types of diabetes.   
MEDICINAL PLANTS EXPLORED AS ANTI-
DIABETIC 
Acacia arabica 
Acacia arabica (babul) is used in the traditional Indian 
system of medicine for the treatment and management of 
diabetes. When powdered seeds extract was administered 
to rats in varying doses of 2, 3, 4g/kg; hypoglycemia was 
observed in control rats but not in alloxanised rats. The 
plant extract was found to be secretagogue and requires 
functioning beta cells for activity. Plant extract initiates 
insulin release from beta cells.   
Adansonia digitata 
Different plant parts of Adansonia digitata including leaves, 
bark and fruits are used in traditional African system of 
medicine for the management of diabetes. The plant is also 
consumed as a regular food. For its wide range of medicinal 
properties, the plant is also referred to as "the small 
pharmacy or chemist tree."  [9]. When methanolic stem bark 
extract of  Adansonia digitata was administered to 
streptozotocin-induced diabetic Wistar rats, an appreciable 
reduction in glucose levels was observed that was 
comparable to controlled rats. Progressive increase in dose 
resulted in varying hypoglycemic action of extract. When a 
dose of 100mg/kg was administered, a significant 
reduction in glucose levels was observed after 1, 3, 5 and 7 
hours of extract administration. A dose of 200 mg/kg 
reduced the blood glucose levels significantly after 3, 5 and 
7 hours of administration. A dose of 400 mg/kg showed 
hypoglycemic action after 5 and 7 hours of administration, 
compared to control normal saline. The results were 
suggestive of potential hypoglycemic activity of plant 
extract. 6. 
Adhatoda vasica 
The methanolic extract of leaves of Adhatoda vasica Nees 
(Acanthaceae) caused inhibition of enzyme sucrase that 
catalyses the conversion of sucrose into glucose. The 
possible sucrose inhibitory activity was found due to the 
presence of compounds vasicine and vasicinol in the 
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extract. The IC50 values were found to be 125μM and 
250μM for vasicine and vasicinol respectively. Further 
evaluation of pharmacokinetics data suggested that the 
inhibitory activities of the two compounds were due to the 
inhibition of sucrose hydrolysing activity of α-glucosidase. 
The compounds bound competitively with Ki values of 82 
μM and 183 μM, respectively. These results were 
suggestive of antidiabetic activity of plant extract 
containing vasicine and vascinol. Further exploratory 
studies of the two compounds are required to establish 
them as potential hypoglycemic candidates. 7 
Aegle marmelos 
The leaf extract of Aegle marmelos has been used routinely 
in the traditional Indian system of medicine for the 
management and treatment of diabetes. When a methanolic 
extract of plant's leaves was administered to alloxan 
induced diabetic rats, it showed a significant reduction in 
glucose levels in the blood. Continuous administration of 
extract showed hypoglycemic effects after the 6th day. The 
reduction in glucose levels was found to be around 54% on 
the 12th day of extract treatment. Apart from excellent 
antidiabetic activity, results were also suggestive of 
potential antioxidant activity of plant extract. 8 
Aloe barbadensis 
Aloes are used since ages as traditional remedies for the 
treatment of a variety of diseases. Two fundamental parts 
isolated from aloes are gel and latex. The Aloe vera gel is 
isolated from the leaf pulp while the Aloe latex is the bitter 
yellow exudate that is isolated from the pericyclic tubules 
lying under the leaf’s outer skin. Diabetic rats and normal 
rats showed appreciable improvement in glucose tolerance 
when extracts of aloe gum were administered. [9] Prolonged 
treatment with Aloe barbadensis exudates reduced glucose 
levels in the blood of alloxanised diabetic rats. The possible 
mechanism of action is thought to be due to secretagogue 
effects of plant extract on pancreatic beta cells. Bitter 
principles isolated from the plant also showed 
hypoglycemic effects in diabetic rats. 9 
Andrographis paniculata 
The chloroform extract of Andrographis paniculata roots 
showed excellent antihyperglycemic activity in alloxan-
induced diabetic rats. Acute and chronic studies were also 
performed and a significant reduction in glucose levels was 
observed in both the studies. Induction of albuminuria, 
proteinemia and uremia was inhibited by the plant extract. 
The study supports the traditional usage of plant roots for 
the management of diabetes and indicates antidiabetic 
activity of the plant. 10. 
Anthocephalus indicus 
Anthocephalus indicus is used in Ayurvedic system of 
medicine since the ancient times for the treatment of 
diarrhea, pain, detoxification and as aphrodisiac. Ethanolic 
extract of plant's roots was administered in alloxanized 
diabetic rats to evaluate the antidiabetic, antioxidant and 
antihyperlipidemic activities of plant extract. The study 
was carried out for 21 days with a dose of 500mg/kg. A 
significant decrease in glucose, triglycerides, total 
cholesterol, phospholipid and free fatty acids levels was 
observed. The plant also showed potential antioxidant 
activity. The root extract when used at the dose range of 
100- 400μg/kg, inhibited the generation of superoxide 
anions and hydroxyl radicals in enzymic and non-enzymic 
systems, in-vitro. The results were indicative of 
antidiabetic, lipid-lowering and antioxidant activities of the 
plant. 11 
 Artanema sesamoides 
Methanolic extract of Artanema sesamoides was 
administered in streptozotocin-induced diabetic rats. 
Administration of extract resulted in a significant reduction 
in blood glucose levels with an increase in liver glycogen 
levels in diabetic rats when compared with control rats. 
Increased levels of liver SGPT, SGOT, and serum alkaline 
phosphatase were also suppressed after administration. A 
potential antioxidant activity of plant was also observed. 
Study results indicated a potential antidiabetic activity of 
the plant. Further studies for the isolation and 
characterization of active constituents are required to 
identify antidiabetic constituents. 12 
Azadirachta indica 
Hydroalcoholic extracts of Azadirachta indica showed anti-
hyperglycemic activity when administered in 
streptozotocin-induced diabetic rats. Extract 
administration resulted in increased uptake of glucose and 
deposition of glycogen in rat hemi diaphragm. The plant 
has also shown excellent antioxidant, hepatoprotective, 
antibacterial, antimalarial and antifertility effects. 13 
Boerhavia diffusa 
Commonly known as Punarnava, it is used extensively in 
Indian system of medicine as a diuretic, hepatoprotective 
and for the treatment of various other diseases. Aqueous 
extract of Boerhavia diffusa leaves when given in a dose of 
200mg/kg for 4 weeks to alloxan-induced diabetic rats 
showed a significant decrease in blood glucose levels in 
normal and alloxanized rats. A significant decrease in 
hepatic enzymes was also observed. Rats treated with 
extract also showed significant glucose tolerance. The 
extract showed more antidiabetic activity when compared 
with standard drug glibenclamide (600μg/kg). [14] 
Butea monosperma 
Also known as Butea frondosa, it is found distributed 
throughout the geographical regions of India. in vitro study 
of methanol extract of seeds suggested a significant 
anthelmintic activity, anticonvulsive and hepatoprotective 
activities of the plant. The plant is also used traditionally 
for the management of diabetes. Significant reduction in 
blood glucose levels was observed in normal and alloxan-
induced diabetic mice. Results indicate the antidiabetic 
potential of the plant. 15 
Caesalpinia bonducella 
The Plant is found to be widely distributed throughout 
India and other tropical regions around the globe. 
Hypoglycemic activity of four different extracts (petroleum 
ether, ether, ethyl acetate and aqueous) of the seed kernels 
was tested in normal and alloxan induced diabetic rats. 
Polar extracts (ethyl acetate and aqueous) showed 
significant hypoglycemic activity in diabetic rats. The 
hypoglycemic effect was comparable to standard drug 
glibenclamide. Diabetes-induced changes in lipid profiles 
and liver functioning were also restored after the 
treatment with polar extracts. Non-polar extracts showed 
insignificant antidiabetic activity. Phytochemical screening 
of polar extract confirmed the presence of triterpenoids 
and glycosides. 16 
Cassia auriculata 
C. auriculata is found commonly in Asian countries and 
used and widely used in the Ayurvedic system of medicine. 
Its extract is used as a tonic, astringent and in the 
treatment of conjunctivitis, ophthalmia and diabetes in the 
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traditional system of medicine in India. It is one of the 
ingredients in the Ayurvedic formulation 
‘‘Avaaraipanchagachooranam” used for the treatment of 
diabetes. Aqueous and ethanolic extracts of the plant have 
shown a significant reduction in blood glucose levels when 
administered in Alloxan-induced diabetic rats (0.25-
0.5g/kg). The plant also showed antihyperlipidemic and 
antidiabetic activity in streptozotocin-induced diabetic 
rats.  Phytochemical screening of plant extract confirmed 
the presence of flavonoids and phenolics. Ethanolic extract 
showed more prominent antidiabetic potential in 
comparison to aqueous extract. Study doses also resulted in 
significant hypolipidemia in addition to anti-diabetic 
activity in the streptozotocin-induced diabetic model 17. 
Cocinia Indica 
Orally administered extract of leaves of Cocinia Indica  at a 
dose of 500 mg/kg resulted in significant hypoglycemia in 
alloxanized dogs. Glucose tolerance was also increased in 
normal and diabetic dogs after the treatment with plant 
extract. 18 
Eugenia jambolana 
Eugenia jambolana is used traditionally in India for the 
management of diabetes. The plant is also added in various 
herbal formulations for the treatment of diabetes. Alcoholic 
and aqueous extracts of the plant have shown significant 
anti-hyperglycaemic effects. Around 75% reduction in 
glucose levels was observed in cases of mild diabetes 
(plasma sugar >180 mg/dl). Around 55% and 17% 
reduction in glucose was observed in cases of moderate 
(plasma sugar >280 mg/dl) and severe diabetes (plasma 
sugar >400 mg/dl) respectively. Studies on pulp extract of 
the plant showed significant hypoglycemic activity in 
streptozotocin-induced diabetic mice within 30 minutes of 
administration. Seed extract showed hypoglycemic effects 
within 24 hours. in vitro studies suggest a secretagogue 
effect of plant extract on isolated islets of Langerhans from 
normal and diabetic rats. Inhibition of insulinase activity 
was also observed in liver and kidney cells.  19 
Ficus bengalensis 
Also known as a banyan tree, it is found to be widely 
distributed throughout the Indian subcontinent. The bark 
of Ficus bengalensis is used traditionally in India for the 
treatment of diabetes. Ethanolic extract of Ficus bengalensis 
showed significant glucose lowering activity were 
comparatively evaluated for their blood glucose lowering 
activity. Ethanolic extract of fruit at a dose of 120mg/kg 
showed more prominent antidiabetic activity when 
compared with root or bark extract. Hypoglycemic activity 
of the extract was comparable to that of standard drug 
glibenclamide. 20 
Ficus racemosa 
Methanolic extract of stem bark of Ficus racemosa given at 
the doses of 200mg/kg and 400mg/kg to normal and 
alloxan-induced diabetic rats showed significant 
hypoglycemic effects of extract both groups. The effects 
were comparable to that of standard drug glibenclamide. 
The study confirmed the traditional claim of the 
antidiabetic effect of the plant. 21 
Hemidesmus indicus 
Hemidesmus indicus has been used traditionally for the 
treatment of veneral diseases, skin diseases, urinary 
infections and infertility. Hypoglycemic activity of aqueous 
plant extract (500mg/kg/day) was evaluated on blood 
glucose with fed, fasted and glucose-loaded diabetic and 
nondiabetic rat models. Significant reduction in blood 
glucose levels with the restoration of serum electrolytes, 
glycolytic enzymes and hepatic CYP450 was observed due 
to the reduction in lipid peroxidation products levels at the 
end of 12 weeks long study. Results were indicative of 
antidiabetic and antioxidant potential of the plant. 22 
Hibiscus rosa-sinesis 
Commonly known as Gudhal, is a flowering tree distributed 
throughout India. Both acute and subacute models were 
used for the evaluation of antidiabetic activity of plant 
extract. Rats were administered with ethanolic extract of 
flower at doses of 250mg/kg and 500mg/kg. An 
appreciable reduction in blood glucose levels was observed 
in both the models. For acute model, reduction in glucose 
levels was observed after 1, 3, 5 hours of extract treatment. 
Reduction in glucose levels was observed after 1, 3, 5, 7 
days of treatment with extract in case of the sub-acute 
model. Results suggested the applicability of ethanolic of 
plant extract in both acute and chronic diabetic 
complications. 23 
Holarrhena antidysenterica 
Also known as kurchi, Holarrhena antidysenterica is an 
indigenous plant distributed throughout in Indian 
subcontinent. Evaluation of hypoglycemic effects of seeds of 
the plant was done on albino rats. Study groups were 
comprised of normal control that received normal saline 1.5 
ml/kg, normal rats treated with 350 mg extract/kg, diabetic 
rats treated with normal saline 1.5ml/kg and diabetic rats 
treated with 350 mg extract/kg. The standard group 
received standard drug glibenclamide 0.5mg/kg. Reduction 
in glucose levels was observed after the 7th day of extract 
administration. The reduction was significant in both 
preprandial and postprandial glucose levels. Reduction in 
glucose levels was also seen in normal rats. Decrease in 
glucose levels from the 7th day was 142.5±1.82 and 
182.5±5.88 in fasting and fed state respectively. No 
significant antihyperlipidemic effect was observed on 
normal rats however, improvement in lipid profile was 
observed in diabetic rats from the day 7. Particularly, 
antihypercholesterolemic activity was evident from day 14. 
On the 28th day, lipid levels observed were 63.80±3.35 and 
84.27±3.07 mg/100 ml in fasting and fed state respectively. 
An appreciable reduction in blood urea nitrogen levels on 
the 28th day was also observed. 24 
Lawsonia inermis 
Lawsonia inermis is commonly known as mehndi in India. It 
has been widely used traditionally for the treatment of 
diabetes. The validity of traditional claim was confirmed in 
a study carried out on alloxanized rats. Extract of plant 
leaves was prepared and administered in normal and 
diabetic rats at a dose of 800mg/kg body weight. Reduction 
in glucose levels was observed on the 14th day of the study. 
Glucose level was reduced from 194mg/dl to normal levels. 
Significant reduction in lipid profile was also observed. 25 
Lepidium sativum 
Aqueous extract of Lepidium sativum seeds was evaluated 
for its hypoglycemic effect. The study included normal and 
streptozotocin-induced diabetic rats. Both acute and 
chronic studies were performed and a significant reduction 
in glucose levels at dose 20mg/kg was observed. 
Normalization of glucose levels was seen after 2 weeks of 
extract administration. A significant reduction in glucose 
levels was observed in normal rats in both acute and 
chronic studies. Basal plasma insulin levels were found not 
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affected in both diabetic and normal rats indicating a 
mechanism of action independent of insulin release. 26 
Momordica Charantia  
Momordica charantia or bitter melon is traditionally used 
as an antidiabetic and antihyperglycemic plant in India and 
in other Asian countries. Various studies performed on 
Extracts of fruit pulp, seed, leaves and whole plant have 
shown an appreciable hypoglycemic effect in animals. A 
Polypeptide p, isolated from fruit, seeds and tissues of M. 
charantia when administered subcutaneously in langurs 
and humans has shown significant hypoglycemic effects. 
Ethanolic extracts of the plant at a dose of 200 mg/kg when 
given to normal and streptozotocin-induced diabetic rats 
showed good anti-hyperglycemic and also hypoglycemic 
effects. Inhibition of enzymes glucose-6-phosphatase, 
fructose-1, 6-biphosphatase with stimulation of hepatic 
glucose-6-phosphate is assumed to be the possible 
mechanism of action of the plant. 27 
Myristica fragrans  
Commonly known as Nutmeg, Myristica fragrans is used 
traditionally for the treatment of diarrhoea, mouth sores 
and insomnia. Petroleum ether extract of seeds 
(200mg/kg) was administered to normal, alloxanized (120 
mg/kg, s.c.) and glucose fed (1.5 g/kg, p.o.) rats. Each group 
consisted of n=5 rats. A significant reduction in glucose 
levels was observed in normal rats. The reduction was from 
56.5±3.19 to 49.75±2.05 mg% in 4 hours, from 
145.75±9.65 to 81.5±4.03 mg% in oral glucose tolerance 
test (OGTT) at ½ h compared to control glucose-fed rats, 
from 305.8±12.49 to 276.6±6.11 mg% after single dose 
treatment and from 326.25±7.05 to 268.0±9.6 mg% in 
alloxan-induced diabetic rats. The treatment with extract 
was continued daily for two weeks. Body weight was also 
reduced after treatment with extract. Improvement in lipid 
profile and haemoglobin content was also noticeable when 
compared to diabetic control rats. 28 
Ocimum sanctum 
Ocimum sanctum is commonly known as tulsi plant. It is 
employed traditionally for the treatment of a variety of 
disorders. Earlier studies performed on leaves of the plant 
have confirmed the glucose lowering activity of the plant in 
diabetic rats and humans. A study on complete ethanolic 
extract and different fractions (aqueous, butanol, ethyl 
acetate) of leaves extract were carried out to determine the 
mechanism of action and effect on insulin secretion. 
Stimulation of insulin secretion occurred in isolated islets 
and in a clonal ratß-cell line in a concentration-dependent 
manner when complete ethanolic extract and fractions of 
extracts were administered to diabetic rats. 
The stimulatory effects of these extracts were elevated with 
glucose, isobutylmethylxanthine, tolbutamide and a 
depolarizing concentration of KCl. Diazoxide and verapamil 
reduced the secretions of insulin. Two other fractions 
(chloroform and hexane) showed stimulatory effects by 
decreased cell viability. The effects were unaltered in the 
presence of diazoxide and verapamil. Extract was also 
found to increase intracellular Ca2+ in clonal BRIN-BD11 
cells and was partially reduced by verapamil. Study results 
suggested the antidiabetic potential of Ocimum sanctum 
due to its secretagogue effect on islets cells. 29 
Onion (Allium cepa) 
Onion is a native of Eurasia subcontinents and is 
distributed widely throughout the world. The plant is 
regularly consumed as food in almost all parts of the world. 
An active phytoconstituent called allyl propyl disulphide 
(APDS) isolated from the bulb of the plant has shown to 
inhibit the breakdown of insulin by the liver. A significant 
increase in insulin production in the pancreas is also 
observed when the specified amount of APDS was 
administered in experimental rats thus allowing an overall 
increase in insulin levels in the blood to exert its 
antidiabetic potential. 30 
Phyllanthus niruri 
Commonly known as Bhuiamla, is a wild plant found to be 
distributed all over the Indian subcontinent. The plant is 
used extensively in traditional Indian system of medicine 
for the treatment of a variety of disorders including 
diabetes. Antidiabetic potential of the plant was evaluated 
in normal, insulin-dependent diabetes mellitus (IDDM), and 
non-insulin-dependent diabetes mellitus (NIDDM) rats. 
Evaluation of lipid metabolism and antioxidant activity was 
done after administration of alcoholic plant extract. The 
hypoglycemic effect was observed in IDDM affected rats. 
Lipid-lowering and antioxidant activities were observed in 
all animals. Results suggested the antidiabetic and 
independent lipid-lowering potential of the plant. 31 
Pterocarpus marsupium 
It is a large tree that is found in hilly regions of Indian 
subcontinent. A number of phytoconstituents are isolated 
and identified from Pterocarpus marsupium. Beta cells 
degranulation was seen when flavonoid fraction of plant is 
administered. Marsupin, pterosupin and liquiritigenin 
isolated from the tree have improved the lipid profile in 
flavonoid fraction. Another active principle Epicatechin 
that is isolated from the plant has shown insulinogenic 
properties in-vitro. Epicatechin is found to stimulate the 
uptake of Oxygen in fat cells and increases the glycogen 
content in the diaphragm of the rat in a dose-dependent 
manner. 32 
Rubia cordifolia 
Rubia cordifolia is a popular herb in the traditional system 
of medicine. It is commonly known as majit. Aqueous roots 
extract of Rubia cordifolia when administered in 
streptozotocin-induced diabetic rats, an appreciable 
reduction in blood glucose levels with improvement in lipid 
profile was observed. The root extract also improved the 
liver functioning by the reduction in serum transaminases 
levels in the blood. The extract had minimum effects of 
hypercholesterolemia. The results were suggestive of 
significant hepatoprotective, antidiabetic and 
antihyperlipidemic activity of the plant. 33 
Terminalia chebula 
Terminalia chebula is commonly known as hard or hartiki 
in India. It is frequently used in Ayurveda for the 
management and treatment of diabetes. Antidiabetic 
activity of Terminalia was evaluated in streptozotocin-
induced diabetic rats. Ethanolic extract of fruits of the plant 
at a dose of 200mg/kg was administered to animals for 30 
days. Reduction in glucose and glycosylated haemoglobin 
(Hba1C) was measured and a significant reduction in 
glucose and Hba1C was seen in diabetic rats. An insulin 
stimulating effect was confirmed by measuring the plasma 
insulin levels. Carbohydrate metabolizing enzymes were 
normalized after extract administration for 30 days. 
Histopathological studies revealed the normalization of 
histopathological abnormalities at end of the study. 34 
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Tinospora cordifolia 
It is a deciduous climbing shrub commonly known as 
Guduchi and found widely distributed in the Indian 
subcontinent. 6 weeks long treatment with aqueous extract 
(400mg/kg) showed a significant reduction in glucose 
levels in blood and urine in alloxan-induced diabetic rats. 
Improvement in lipid profiles in serum and tissues was also 
observed. Falling body weight was normalized after the 
treatment. The hypoglycemic effect was equivalent to 1 
unit/kg of insulin. Continuous administration of extract 
showed a significant reduction in glucose levels and 
increased glucose tolerance in rodents. 35 
Trigonellafoenum-graceum  
 foenum-graecum or fenugreek is consumed as food and 
spice in the Indian subcontinent. The plant is cultivated 
worldwide and is used as a herb and as a spice (seeds) 
around the world. Blood sugar levels of diabetic patients 
were reduced with the administration of fibre rich fractions 
of seeds. The plant seeds have also improved the lipid 
profile of diabetic patients to some extent when a dose of 5-
30g of seeds was given to the patients. The seeds also 
result in mild digestive distress in patients taking seeds. 
The fibre-rich fraction of fenugreek seeds can lower blood 
sugar levels in people with diabetes, and to a lesser extent, 
lowers blood cholesterol. Additionally, the soluble fibre 
content of fenugreek may play a role in aiding weight 
control. A typical dose range is 5 to 30 g three times per 
day with meals. Known side effects of high doses include 
mild digestive distress. Fenugreek should not be used by 
pregnant or nursing women 36. 
Withania somnifera 
Commonly known as Ashwagandha, it is used widely in 
traditional medicine for the treatment and management of 
a variety of disorders including tumours. The roots of the 
plant are found rich in steroidal lactones called 
withanolides. The leaf and root extracts of Withania 
somnifera have shown excellent hypoglycemic and lipid-
lowering effects in alloxan-induced diabetic rats when 
administered with extracts for eight weeks. The results 
obtained were comparable with standard drug 
glibenclamide. Changes in blood glucose and other 
serological parameters to normal levels were observed at 
the end of the study. 37 
DISCUSSION 
Medicinal plants, since the time immemorial, are utilized 
for the purpose of maintaining the well beings of humans. 
Plant-based drugs have gained popularity among the 
general population due to their capability to treat the cause 
of diseases with no or least side effects. A number of 
phytoconstituents isolated from different plants have 
established themselves as potential drug candidates for the 
treatment or management of diseases. Apart from their 
capability of treating a disease with least side effects 
possible, natural drugs are also gaining affinity due to their 
affordability, ease of access and acceptability based on the 
historical claims. The capability of medicinal plants to cure 
diseases which are otherwise non-curable in the rational or 
modern system of medicine has further consolidated the 
faith of humans in natural approaches. Medicinal plants act 
by multi-target approaches and target more than one 
biological target at a time. This multi-target capability of 
plants prevents the failure of a therapy for the disease 
treatment. 
Diabetes is a metabolic disorder. Its treatment therapy 
includes replacement therapy and administration of 
hypoglycemic agents for type-1 and type-2 diabetes 
respectively. The treatment regimen of diabetes includes 
the approaches for the management of diabetes. No drug 
has been discovered so far that can treat the cause of 
diabetes and provide a complete cure from the disease. 
Traditional systems of medicines have claimed to cure 
diabetes by using herbal principles. Plants are extensively 
evaluated to determine their potential in the treatment of 
diabetes. Majority of plants that are evaluated have shown 
the excellent capability to reduce the blood sugar levels 
along with other the improvement in lipid profiles and liver 
functioning. This approach of medicinal plants to treat 
multiple causes simultaneously makes them capable to 
control the disease progression through multiple 
mechanisms.  
If explored appropriately, plants can be the infinite sources 
of active principles that can cure the diseases and disorders 
with the occurrence of minimum side effects. Medicinal 
plants that show prominent antidiabetic activity in the 
initial studies should be further explored to isolate and 
characterize active phytoconstituents that can become 
possible drug candidates in the near future.   
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